{"name":"Michael A. Matthay","slug":"michael-a-matthay","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Plasma-Lyte A","genericName":"Plasma-Lyte A","slug":"plasma-lyte-a","indication":"Fluid and electrolyte replacement in dehydration","status":"marketed"}]}],"pipeline":[{"name":"Plasma-Lyte A","genericName":"Plasma-Lyte A","slug":"plasma-lyte-a","phase":"marketed","mechanism":"Plasma-Lyte A is a balanced crystalloid electrolyte solution that replaces fluid and electrolytes lost through dehydration, hemorrhage, or other causes.","indications":["Fluid and electrolyte replacement in dehydration","Perioperative fluid management","Hemorrhage and hypovolemia management","Maintenance of electrolyte balance in hospitalized patients"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE1oV1ZOVzhOOWJrbE16TzJmX25INnM1Q3RJSnlBUS1SblR4aWhiVnd4M1VCRndOajJNaTg4X1dQaEtsYUMxdWZJTk81VENaOEVCQ2JVWC0xVm44THNWY3NIQU1PRkNQUVBSMkZfdg?oc=5","date":"2024-10-28","type":"pipeline","source":"The BMJ","summary":"Acute respiratory distress syndrome - The BMJ","headline":"Acute respiratory distress syndrome","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAJBVV95cUxQNW9JYnRIS0lXMzk0TE40eUlhbWJHTGFvN2lPejJrY29ta1l2VGNhNEJrX0tGRS1MNVdqLVl3Vlo2LWFJaFByZENvVG0ySi0yUmMyS2t2QmRYLVJoQ3ZxVFlWZ1ktNnJlc3ZUWmNyOTREamFEellNYnVwdkROSXhNdjdnM2Y5U1lJeWV6T0VmMHBuTzNTQm9oNEVCYkZUelJJSUxKUnZZV1g2SDA5aHhocFRIeHpXbmNVUFJ6Z2NLQl9YVlFLNXBVTmJtc21mUXBkT05KcVYtV01SbjRhVkhfWmhtSG9IRTljLVBuSFJOTHJfQTFGVkpmRGowZEJUTkt2aVZkaHZfRXlTUFlkWTZwQ0Z0Wk1BMzZ3b1BYOA?oc=5","date":"2021-06-15","type":"pipeline","source":"prnewswire.com","summary":"Citius Pharmaceuticals Expands Scientific Advisory Board with Addition of Dr. John Laffey, Expert in Stem Cell and Gene Therapies for ARDS - prnewswire.com","headline":"Citius Pharmaceuticals Expands Scientific Advisory Board with Addition of Dr. John Laffey, Expert in Stem Cell and Gene ","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}